IPBronch.com | Interventional Pulmonology

TLCR Oct 27, 2026

Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey

Study Takeaway

Highlights the critical importance of obtaining adequate tissue via bronchoscopic biopsies for comprehensive molecular profiling.

Authors not listed

IP Score: 6/10 View Analysis →

JTD Oct 27, 2026

Superior sulcus (Pancoast) tumors: current evidence on diagnosis and radical treatment

Study Takeaway

Relevant for IP specialists involved in the bronchoscopic and image-guided tissue diagnosis and staging of apical lung masses.

Authors not listed

IP Score: 6/10 View Analysis →

JTD Oct 27, 2026

Management of incidental lung nodules <8 mm in diameter

Study Takeaway

Relevant to IP practices managing pulmonary nodules discovered during staging or diagnostic workups.

Authors not listed

IP Score: 6/10 View Analysis →

Thorax Oct 22, 2026

Guideline adherence to invasive mediastinal staging in contemporary resectable NSCLC trials: a systematic review.

Study Takeaway

Highlights the critical role of EBUS-TBNA and mediastinoscopy in clinical trial quality control and accurate lung cancer staging.

Contreras-Garza BM; Flores-Mejia J; Martinez-Valenciano JM; Sanchez-Soto C; Jimenez-Lopez J; Guzmán-Delgado NE

IP Score: 7/10 View Analysis →

Chest Oct 3, 2026

CEUS- versus US- and CT-guided Biopsy for Subpleural Lung Lesions: A Prospective, Multicenter Randomized Controlled Trial.

Study Takeaway

Provides valuable comparative data on image guidance modalities for sampling peripheral pulmonary lesions, impacting procedural planning.

Bi K; Shen MJ; Xu D; Tang Q; Sun YX; Ye XF

IP Score: 6/10 View Analysis →

Thorax Aug 14, 2026

Upstaging of screen-detected lung cancers during diagnostic assessment.

Study Takeaway

Relevant to the timing and diagnostic strategies utilized in bronchoscopic evaluation of screen-detected lung cancer.

Mullin ML; Verghese P; Khaw CR; Creamer A; Bhamani A; Prendecki R

IP Score: 6/10 View Analysis →

Chest Aug 5, 2026

Systematic review and meta-analysis of FDG PET-CT for nodal staging of part-solid lung adenocarcinomas.

Study Takeaway

Relevant for staging and selecting patients who may require bronchoscopic mediastinal staging (like EBUS).

Choy PM; Wong HYA; Lim EKS; Hare SS; Patel ARC; Pencharz D

IP Score: 6/10 View Analysis →

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Jul 30, 2026

Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.

Study Takeaway

Provides broader context on multidisciplinary management of NSCLC that impacts staging and biopsy referrals.

Meyer ML; Peters S; Borghaei H; Cascone T; Dacic S; Faivre-Finn C

IP Score: 6/10 View Analysis →

Chest Jul 28, 2026

Development and Multi-center Validation of a Breathomics-Based Triage Tool for Lung Cancer: A Prospective Study of 5,214 Participants.

Study Takeaway

Non-invasive triage tools may eventually alter referral patterns for diagnostic bronchoscopy and nodule management.

Qin J; Sun M; Li X; Duan X; Li Y; Ma H

IP Score: 6/10 View Analysis →

American journal of respiratory and critical care medicine Jul 27, 2026

Tool In Lesion- But Still Off Target: A Call of Concern for Lung Cancer Screening.

Study Takeaway

Highlights ongoing limitations in targeting peripheral pulmonary lesions during screening and bronchoscopy.

Schwartz J; Murn M; Laniado I; Studts JL; Bade BC

IP Score: 6/10 View Analysis →

Chest Jul 16, 2026

Evolving Lung Cancer Navigator Practice Through Targeted Professional Development: A Long-term Outcomes Analysis.

Study Takeaway

Highlights the importance of multidisciplinary coordination in the IP lung cancer diagnostic pathway.

Lloyd SJ; Mortman MF; Monahan PO; Slaven JE; Lemery C; Podsiad M

IP Score: 6/10 View Analysis →

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Jul 14, 2026

Comparison of circulating tumor DNA assays for molecular residual disease detection in non-small cell lung cancer.

Study Takeaway

Relevant to the diagnostic and monitoring pathway for lung cancer patients often managed by IP for biopsy and staging.

Cui Q; Zhang JT; Yin H; Zhang KP; Xu J; Xu FP

IP Score: 6/10 View Analysis →

Literature Archives